PRKN and Parkinson disease: Future work should define quantitative thresholds and molecular determinants of ROS–mitophagy coupling and develop combination strategies that both mitigate oxidative stress and precisely activate PINK1/Parkin-dependent mitophagy, with the goal of disease modification in PD.